You just read:

Oxis Praises Biden's 'Cancer Moonshot,' Says its Portfolio of Targeted Immunotherapies Provides Next-Generation Cancer Treatments

News provided by

Oxis International, Inc.

31 Mar, 2016, 08:00 ET